Although improvements in other endpoints such as OSDI, tear film breakup time, and corneal fluorescein staining did not reach statistical significance, the treatment demonstrated a favorable safety profile, with no adverse effects on visual acuity or intraocular pressure.
← all excerpts
Current Diagnosis and Management of Ocular Graft-Versus-Host Disease at a Tertiary Cancer Center.
1
—
—